Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pleno
AddedFeb 17, 2024
UpdatedJun 18, 2026
Pleno

Pleno

Series A

Pleno Inc., a San Diego-based early-stage startup, specializes in biotechnology.

HQ
San Diego, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Pleno Inc., founded in San Diego, is an early-stage biotechnology startup with a mission to revolutionize genomic testing. The company's vision is to make genomic testing affordable, accessible, and rapid, providing comprehensive multi-omic insights from a single patient sample. Pleno offers innovative solutions that aim to transform lab economics by delivering same-day results, which traditionally take a week or more. Their core product focuses on enhancing the efficiency and profitability of clinical genomics labs.

Pleno has attracted notable investors and industry experts who believe in its transformative potential. The company has achieved significant milestones in developing its foundational technology, positioning itself as a pioneer in the genomics field. By making genomic testing more accessible and efficient, Pleno is poised to have a substantial impact on healthcare, enabling more timely and accurate diagnoses and treatments.

Pleno - Similar Companies

Singular Genomics logo

Singular Genomics

Nest Genomics logo

Nest Genomics

nestgenomics.com

OmniVis logo

OmniVis

Paragon Genomics logo

Paragon Genomics

Genalyte logo

Genalyte

genalyte.com

MicroPure Genomics logo

MicroPure Genomics

Geneicd logo

Geneicd

Cradle Genomics logo

Cradle Genomics

Navipoint Genomics logo

Navipoint Genomics

Lunadna logo

Lunadna

Allelica logo

Allelica

allelica.com

Station X logo

Station X

Clear Labs logo

Clear Labs

clearlabs.com

Tempus logo

Tempus

tempus.com

Genendeavor logo

Genendeavor

genendeavor.com

Pleno - Quick Facts

Who are Pleno's competitors?

Companies similar to Pleno include Singular Genomics, Nest Genomics, OmniVis and Paragon Genomics.

When was Pleno founded?

Pleno was founded in 2017.

Where is Pleno's headquarters located?

Pleno's headquarters is located in San Diego, CA, US.

When was Pleno's last funding round?

Pleno's most recent funding round was for $40M (USD) in October 2022.

How much has Pleno raised to-date?

As of Oct 12, 2022, Pleno has raised a total of $55M (USD).

How many employees does Pleno have?

Pleno has 62 employees as of Feb 4, 2024.

Pleno - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Genomic Testing
Tags
  • Biotech
  • Data
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software